Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05607017 · ClinicalTrials.gov registry record · Early Phase 1
Losartan in Prevention of Radiation-Induced Heart Failure
A Early Phase 1 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
NCT05607017: Completed Early Phase 1 study, sponsored by Massachusetts General Hospital.
NCT05607017 is a Early Phase 1 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05607017, a Early Phase 1 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study is being done to see if losartan affects the chances of developing radiation-induced heart failure in patients who are receiving radiation therapy as part of standard of care treatment for breast cancer. The interventions involved in this study are: * Losartan * Radiation Therapy (standard of care)
Interventions
- RADIATION Radiation Therapy
- DRUG Losartan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2023-09-13 |
| Est. Completion | 2025-10-07 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05607017
The ClinicalTrials.gov registry entry for NCT05607017 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Radiation Therapy is the first listed.
NCT05607017 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05607017 about?
NCT05607017 is a clinical study titled "Losartan in Prevention of Radiation-Induced Heart Failure". This study is being done to see if losartan affects the chances of developing radiation-induced heart failure in patients who are receiving radiation therapy as part of standard of care treatment for breast cancer. The interventions involved in this study are: * Losartan * Radiation Therapy (stand...
What is the current status of trial NCT05607017?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2023-09-13. Estimated completion is 2025-10-07.
What interventions are being tested in trial NCT05607017?
The interventions under investigation include: Radiation Therapy (RADIATION), Losartan (DRUG).
Who is sponsoring clinical trial NCT05607017?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.